BRIAN JALBERT: Open Payments
NPI 1790814564 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,631 in 72 payments from 16 companies in 2025. Trend: 2023 $1,198 · 2024 $1,762 · 2025 $1,631
Food & beverage: $1,451Education: $180
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $305 |
| UCB, Inc. | 10 | $296 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 15 | $278 |
| ABBVIE INC. | 8 | $202 |
| Janssen Scientific Affairs, LLC | 1 | $102 |
| Lilly USA, LLC | 5 | $95 |
| Arcutis Biotherapeutics, Inc. | 4 | $67 |
| Amgen Inc. | 4 | $63 |
| GENZYME CORPORATION | 2 | $56 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
Products named: TREMFYA, Bimzelx, SKYRIZI, ILUMYA, TALTZ, Zoryve, OTEZLA, DUPIXENT.
Industry payments across VA — which companies pay providers there.
